Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

  • M. Hardy-Werbin
    Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  • O. Arpí
    Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  • A. Taus
    Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain
  • P. Rocha
    Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain
  • D. Joseph-Pietras
    NIHR Experimental Cancer Medicine Centre, Southampton, United Kingdom
  • L. Nolan
    Medical Oncology Department, University Hospital Southampton, Southampton, United Kingdom
  • S. Danson
    Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, Sheffield, United Kingdom
  • R. Griffiths
    Medical Oncology Department, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom
  • M. Lopez-Botet
    Immunology unit, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  • A. Rovira
    Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  • J. Albanell
    Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
  • C. H. Ottensmeier
    Cancer Science Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
  • E. Arriola
    Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

収録刊行物

  • OncoImmunology

    OncoImmunology 7 (2), e1395125-, 2017-11-27

    Informa UK Limited

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ